Paracetamol overdose advice updated

The CHM has simplified instructions for the use of intravenous acetylcysteine in the treatment of acute paracetamol overdose.

Paracetamol overdose can result in liver damage and death. | SCIENCE PHOTO LIBRARY
Paracetamol overdose can result in liver damage and death. | SCIENCE PHOTO LIBRARY

Intravenous acetylcysteine is now licensed to treat paracetamol overdose in the following circumstances:

  • irrespective of plasma paracetamol level where the overdose is staggered (that is, taken over one hour or more) or there is doubt over the time of paracetamol ingestion
  • where the timed plasma paracetamol concentration is on or above a single treatment line joining points of 100mg/L at 4 hours and 15mg/L at 15 hours on a revised overdose treatment nomogram, regardless of risk factors for hepatotoxicity.

The CHM has also made a number of other recommendations intended to reduce the risks to patients, including:

  • an increase in the duration of administration of the first dose of intravenous acetylcysteine from 15 minutes to 1 hour
  • the removal of hypersensitivity as a contraindication to treatment with acetylcysteine
  • the provision of weight-based dosing tables for adults and children, removing the need to calculate the dose
  • the inclusion of a Technical Information Leaflet for healthcare professionals in every pack of acetylcysteine, providing more detailed instructions on the preparation of acetylcysteine infusions.

View acetylcysteine drug record

Follow MIMS on Twitter


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases